Health state | Utility | Source & calculation |
---|---|---|
PP1M | ||
Stable: Adherent | 0.865 | Layperson sample |
Stable: Non-adherent | 0.865 | Assumed equal to Stable: Adherent |
Relapse: Hospitalization | 0.479 | Layperson sample |
Relapse: Ambulatory care | 0.479 | Layperson sample |
Death | 0.000 | Assumed 0.000 |
PP3M | ||
Stable: Adherent | 0.916 | Layperson sample and added benefit for time between injections |
Stable: Non-adherent | 0.865 | Assumed equal to Stable: Adherent |
Relapse: Hospitalization | 0.479 | Layperson sample |
Relapse: Ambulatory care | 0.479 | Layperson sample |
Death | 0.000 | Assumed 0.000 |
Treatment Interruption | ||
Stable: Adherent | 0.865 | Layperson sample |
Stable: Non-adherent | 0.865 | Assumed equal to Stable: Adherent |
Relapse: Hospitalization | 0.479 | Layperson sample |
Relapse: Ambulatory care | 0.479 | Layperson sample |
Death | 0.000 | Assumed 0.000 |
Utility decrements for adverse events | ||
Acute EPS | 0.291 | Layperson sample (0.865–0.574) |
Weight gain | 0.086 | Layperson sample (0.865–0.779) |
Diabetes | 0.153 | Layperson sample (0.865–0.712) |